Clik here to view.
Bayer’s antibiotic drug-device combo fails in late-stage trial
Bayer (ETR:BAYN) reported last week that its antibiotic drug-device combination product failed in a phase III trial. In the 725-patient Inhale trial, Bayer’s Amikacin Inhale did not out-perform a...
View ArticleClik here to view.
GSK to use Owlstone’s breath biopsy device in Phase II COPD trial
GlaxoSmithKline (NYSE:GSK) is slated to use Owlstone Medical‘s breath biopsy device in a phase II trial of its drug for chronic obstructive pulmonary disease, danirixin. The diagnostics company’s...
View ArticleClik here to view.
Kala Pharmaceuticals taps biopharma exec as chief operating officer |...
Kala Pharmaceuticals (NSDQ:KALA) this month expanded its team of C-suite executives, naming Todd Bazemore as chief operating officer. Bazemore has spent more than 20 years in the biopharmaceutical...
View ArticleClik here to view.
Egalet’s extended-release, abuse-deterrent opioid succeeds in Ph3 trial
Shares in Egalet Corp. (NSDQ:EGLT) soared this morning in pre-market activity after the company reported that its abuse-deterrent, extended-release oxycodone candidate met the primary endpoint of a...
View ArticleClik here to view.
One Drop wants to help lead a healthcare revolution for people with diabetes...
When Jeff Dachis was diagnosed with Type I diabetes four years ago, he remembers leaving the doctor’s office with a sinking feeling in his chest. “I had about six minutes with a nurse practitioner and...
View ArticleClik here to view.
Dexcom inks continuous glucose monitoring deal with UnitedHealth
Shares in Dexcom (NSDQ:DXCM) rose 4% today after the company announced a partnership with UnitedHealth (NYSE:UNH) to assess if data from a continuous glucose monitor can help people with Type II...
View ArticleClik here to view.
Onduo taps Glytec’s insulin therapy software as part of virtual diabetes clinic
Glytec has inked a deal with Onduo to integrate the company’s Glucommander Outpatient insulin management software into Onduo’s virtual diabetes clinic. Onduo, a joint venture of Sanofi (NYSE:SNY) and...
View ArticleClik here to view.
Lung cancer expert: Smoking stigma still hurting patients, families and research
A number of therapies designed to treat patients with lung cancer have been approved this year, including products from Novartis (NYSE:NVS), Merck (NYSE:MRK) and Bristol-Myers Squibb (NYSE:BMY). That...
View ArticleClik here to view.
Cordis, Medinol win FDA nod for Elunir drug-eluting stent
Cordis and Medinol announced today that the FDA approved its Elunir drug-eluting stent for the treatment of patients with narrowing or blocked coronary arteries. The stent, designed by Medinol and...
View ArticleClik here to view.
Ascensia Diabetes Care highlights women helping to advance diabetes care
In support of World Diabetes Day earlier this month, Ascensia Diabetes Care published 30 portraits of women who are working to advance diabetes care. The company’s CEO, Michael Kloss, said he was...
View ArticleClik here to view.
FDA approves first once-monthly buprenorphine injection to treat opioid...
Indivior (LON:INDV) shares jumped today after the FDA approved its once-monthly buprenorphine injection for the treatment of opioid addiction in adult patients who have started therapy with a...
View ArticleClik here to view.
Flexion CEO: Setting Zilretta up to succeed with a history lesson
Locally acting therapies are like a religion to Flexion Therapeutics (NSDQ:FLXN) co-founder & CEO Dr. Mike Clayman, who spent decades at Eli Lilly (NYSE:LLY) with the company’s co-founder, Dr. Neil...
View ArticleClik here to view.
FDA’s Gottlieb updates on Puerto Rico and medical product shortages
FDA commissioner Dr. Scott Gottlieb provided an update today to the work that the agency is doing to help medical device manufacturers in Puerto Rico in the weeks following Hurricanes Irma and Maria....
View ArticleClik here to view.
Smith & Nephew deals topical anesthetic gel to Alliance Pharma
Alliance Pharma (LON:APH) has acquired the rights to Smith & Nephew‘s (NYSE:SNN) anesthetic gel Ametop for $7.5 million, according to the specialty pharmaceutical company. The product, which Smith...
View ArticleClik here to view.
Novocure nabs reimbursement for Optune in Japan
Novocure (NSDQ:NVCR) shares were up this morning after the Japanese Ministry of Health, Labour and Welfare agreed to reimburse for Optune as a treatment for newly-diagnosed glioblastoma. The Optune...
View ArticleClik here to view.
CareFusion warns customers about Alaris syringe pump alarm
CareFusion issued a warning to customers of its Alaris syringe drug pump system, cautioning them that pumps made before 2008 may display an error message that could stop the pump from working. The...
View ArticleClik here to view.
CVS Health to buy Aetna in $69B merger
CVS Health (NYSE:CVS) plans to buy health insurer Aetna (NYSE:AET) in a $69 billion merger, according to a report from The New York Times. The deal comes as companies like Amazon (NSDQ:AMZN), which is...
View ArticleClik here to view.
Sanofi touts head-to-head comparison of long-acting insulin products
Sanofi‘s (NYSE:SNY) long-acting insulin glargine, Toujeo, met the primary objective of a head-to-head trial comparing it to Novo Nordisk‘s (NYSE:NVO) insulin degludec, Tresiba, the company reported...
View ArticleClik here to view.
Silicone patch for laser-assisted tattoo removal wins new FDA clearance
Merz North America said today that its Describe PFD patch was cleared by the FDA for all commonly-used lasers. The single-use, perfluorodecalin-infused patch is used during laser-assisted tattoo...
View ArticleClik here to view.
Dance Biopharm, Phillips-Medisize ink deal for inhaled insulin device
Privately-held biotech Dance Biopharm and Phillips-Medisize have entered into a joint development deal for a connected drug-delivery device for inhaled insulin. The agreement gives Phillips-Medisize,...
View Article